JPRN-UMIN000015592已完成未知
Increased presepsin (soluble CD14 subtype) values in surgical patients with chronic kidney disease on hemodialysis even in the absence of infection - Presepsin (soluble CD14 subtype) values in surgical patients with chronic kidney disease
Hirosaki University Graduate School of Medicine, Department of Anesthesiology0 个研究点目标入组 60 人开始时间: 2014年11月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •infectious sign
研究者
相似试验
已完成
不适用
Soluble CD14 subtype (presepsin) levels in the scheduled high-risk surgery patients who candidates ICU admission ; a prospective observational studythe scheduled high-risk surgery patientsJPRN-UMIN000013748Fujita Health University School of Medicine Department of Anesthesiology and Critical Care Medicine150
已完成
不适用
Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis PatientsSepsisNCT03796715Ain Shams University200
已完成
不适用
Diagnostic value of soluble CD14 subtype in neonatal sepsis1000401810028920neonatal sepsisbacterial infectionNL-OMON55522OLVG200
已完成
不适用
Elevated Plasma Level of CD144-Positive Endothelium-Derived-Microparticles Predicts Future Cardiovascular Events in Patients at High-Risk for Coronary Artery DeseasePatients at high-risk for coronary artery diseaseJPRN-UMIN000000876Graduate School of Medical Sciences, Kumamoto University500
已完成
不适用
Correlation of CD147 Expression in Stage-IV Non-Small Cell Lung Cancer with Platinum-Based Chemotherapy Treatment OutcomesStage-IV Non-CD147 (EMMPRIN)advanced stage non-cisplatin-based chemotherapytreatment outcomesSmall Cell Lung Cancersmall cell lung cancerTCTR20190308002Prince of Songkla University242